Vancomycin|OMICS International|Clinical Trials

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.


Vancomycin, a glycopeptide, has long been considered a time-dependent killing antibiotic, and therefore therapeutic drug concentration monitoring by using peak concentrations, troughs, or both, has been practiced for years. Therapeutic drug monitoring for vancomycin has also been largely debated for the same amount of time. Current consensus for treatment of serious S. aureus infections is that vancomycin is a slowly-cidal, time-dependent killing antibiotic However, AUC/MIC, not T>MIC, is the most predictive pharmacodynamic parameter.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on February, 2021